JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JCM Accepts, published online ahead of print on 12 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.00008-08v1
46/5/1682    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Aslanzadeh, J.
Right arrow Articles by Tang, Y.-W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aslanzadeh, J.
Right arrow Articles by Tang, Y.-W.
J. Clin. Microbiol. doi:10.1128/JCM.00008-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Prospective Evaluation of Rapid Antigen Tests for Diagnosis of Respiratory Syncytial Virus and Human Metapneumovirus Infections

Jaber Aslanzadeh*, Xiaotian Zheng, Haijing Li, Janice Tetreault, Irene Ratkiewicz, Shufang Meng, Pamela Hamilton, and Yi-Wei Tang

Hartford Hospital and Clinical Laboratory Partners, Hartford, CT 06102; Children's Memorial Hospital, and Northwestern University, the Feinberg School of Medicine, Chicago, IL 60614; and Departments of Medicine and Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232

* To whom correspondence should be addressed. Email: Jaslanz{at}harthosp.org.


   Abstract

Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are two important viral pathogens causing respiratory tract infections in the pediatric population. Rapid detection of these agents allows for the prompt isolation and treatment of infected patients. In this prospective study, we evaluated the performances of four rapid antigen detection assays including a rapid chromatographic immunoassay (CIA) for RSV (DirectigenTM EZ RSV, Becton Dickinson, Sparks, MD); a DFA test for RSV (Bartels, Trinity Biotech Carlsbad, CA) and two DFA tests for hMPV manufactured by DHI (Diagnostic Hybrids Inc. Athens, OH) and Imagen (Oxoid Ltd., Basingstike, Hampshire, U.K.). Clinical specimens tested were 515 nasopharyngeal aspirates submitted to the Clinical Microbiology Laboratory at Hartford Hospital from November 1, 2006 to April 21, 2007. Compared to real-time reverse-transcription PCR (RT-PCR), the CIA had a sensitivity of 79.8% and a specificity of 89.5 %. RSV DFA using Bartels reagents showed a sensitivity of 94.1% and a specificity of 96.8%. For hMPV, the sensitivity and specificity was 62.5% and 99.8% for DHI DFA, and 63.2% and 100% for Imagen DFA, respectively. The hands-on and test turnaround times for CIA were 10 and 30 to 60 minutes and the hands-on and test turnaround time for RSV and hMPV DFA were 30 and 105 minutes respectively. We conclude that while RSV CIA is user friendly, it lacks sensitivity and specificity especially during off peak months. In contrast, RSV DFA is more sensitive and specific but is subjective and it demands technical time and expertise. Similarly, both hMPV DFA are highly specific in comparison to RT-PCR, but sensitivity awaits further improvement.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.